[Biochemical assumptions and pharmacological bases of a rational therapy of sleep-wakefulness disorders].
D001923:Brain Chemistry; D002395:Catecholamines / Q000378:metabolism; D005060:Europe; D005260:Female; D005860:Germany, West; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000378:metabolism; D012893:Sleep Wake Disorders / Q000378:metabolism*; D019966:Substance-Related Disorders; D009435:Synaptic Transmission; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use
D002395:Catecholamines; D006993:Hypnotics and Sedatives; D018377:Neurotransmitter Agents; D014149:Tranquilizing Agents
Biochemische Voraussetzungen und pharmakologische Grundlagen einer begründeten Therapie von Schlaf-Wachstörungen.